Results for tag: "Polymyalgia Rheumatica Drug"

Polymyalgia Rheumatica (PMR) is a musculoskeletal disorder characterized by pain and stiffness in the neck, shoulders, and hips. Treatment for PMR typically involves the use of non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. The PMR drug market is a subset of the larger musculoskeletal disorder drugs market, which is estimated to be worth billions of dollars. The PMR drug market is expected to grow due to the increasing prevalence of PMR, as well as the development of new drugs and treatments. The market is also driven by the increasing demand for effective treatments for PMR, as well as the rising awareness of the condition. Some of the major companies in the PMR drug market include Pfizer, Novartis, Merck, AbbVie, and Johnson & Johnson. These companies are involved in the development, manufacture, and marketing of drugs for the treatment of PMR. Show Less Read more